BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36335655)

  • 21. Functional Integrin Regulation Through Interactions with Tetraspanin CD9.
    Torres-Gómez Á; Cardeñes B; Díez-Sainz E; Lafuente EM; Cabañas C
    Methods Mol Biol; 2021; 2217():47-56. PubMed ID: 33215376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. OC-STAMP promotes osteoclast fusion for pathogenic bone resorption in periodontitis via up-regulation of permissive fusogen CD9.
    Ishii T; Ruiz-Torruella M; Ikeda A; Shindo S; Movila A; Mawardi H; Albassam A; Kayal RA; Al-Dharrab AA; Egashira K; Wisitrasameewong W; Yamamoto K; Mira AI; Sueishi K; Han X; Taubman MA; Miyamoto T; Kawai T
    FASEB J; 2018 Jul; 32(7):4016-4030. PubMed ID: 29533736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tetraspanin CD9 regulates cell contraction and actin arrangement via RhoA in human vascular smooth muscle cells.
    Herr MJ; Mabry SE; Jennings LK
    PLoS One; 2014; 9(9):e106999. PubMed ID: 25184334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transmembrane protein CD9 is glioblastoma biomarker, relevant for maintenance of glioblastoma stem cells.
    Podergajs N; Motaln H; Rajčević U; Verbovšek U; Koršič M; Obad N; Espedal H; Vittori M; Herold-Mende C; Miletic H; Bjerkvig R; Turnšek TL
    Oncotarget; 2016 Jan; 7(1):593-609. PubMed ID: 26573230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Site-specific functionality and tryptophan mimicry of lipidation in tetraspanin CD9.
    Neviani V; van Deventer S; Wörner TP; Xenaki KT; van de Waterbeemd M; Rodenburg RNP; Wortel IMN; Kuiper JK; Huisman S; Granneman J; van Bergen En Henegouwen PMP; Heck AJR; van Spriel AB; Gros P
    FEBS J; 2020 Dec; 287(24):5323-5344. PubMed ID: 32181977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD9 Regulates Major Histocompatibility Complex Class II Trafficking in Monocyte-Derived Dendritic Cells.
    Rocha-Perugini V; Martínez Del Hoyo G; González-Granado JM; Ramírez-Huesca M; Zorita V; Rubinstein E; Boucheix C; Sánchez-Madrid F
    Mol Cell Biol; 2017 Aug; 37(15):. PubMed ID: 28533221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional analysis of four tetraspans, CD9, CD53, CD81, and CD82, suggests a common role in costimulation, cell adhesion, and migration: only CD9 upregulates HB-EGF activity.
    Lagaudrière-Gesbert C; Le Naour F; Lebel-Binay S; Billard M; Lemichez E; Boquet P; Boucheix C; Conjeaud H; Rubinstein E
    Cell Immunol; 1997 Dec; 182(2):105-12. PubMed ID: 9514697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deletion of tetraspanin CD9 diminishes lymphangiogenesis in vivo and in vitro.
    Iwasaki T; Takeda Y; Maruyama K; Yokosaki Y; Tsujino K; Tetsumoto S; Kuhara H; Nakanishi K; Otani Y; Jin Y; Kohmo S; Hirata H; Takahashi R; Suzuki M; Inoue K; Nagatomo I; Goya S; Kijima T; Kumagai T; Tachibana I; Kawase I; Kumanogoh A
    J Biol Chem; 2013 Jan; 288(4):2118-31. PubMed ID: 23223239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD9, a potential leukemia stem cell marker, regulates drug resistance and leukemia development in acute myeloid leukemia.
    Liu Y; Wang G; Zhang J; Chen X; Xu H; Heng G; Chen J; Zhao Y; Li J; Ni Y; Zhang Y; Shan J; Qian C
    Stem Cell Res Ther; 2021 Jan; 12(1):86. PubMed ID: 33494824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The tetraspanin CD9 facilitates MERS-coronavirus entry by scaffolding host cell receptors and proteases.
    Earnest JT; Hantak MP; Li K; McCray PB; Perlman S; Gallagher T
    PLoS Pathog; 2017 Jul; 13(7):e1006546. PubMed ID: 28759649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD9 identifies pancreatic cancer stem cells and modulates glutamine metabolism to fuel tumour growth.
    Wang VM; Ferreira RMM; Almagro J; Evan T; Legrave N; Zaw Thin M; Frith D; Carvalho J; Barry DJ; Snijders AP; Herbert E; Nye EL; MacRae JI; Behrens A
    Nat Cell Biol; 2019 Nov; 21(11):1425-1435. PubMed ID: 31685994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastoma.
    Fabian J; Opitz D; Althoff K; Lodrini M; Hero B; Volland R; Beckers A; de Preter K; Decock A; Patil N; Abba M; Kopp-Schneider A; Astrahantseff K; Wünschel J; Pfeil S; Ercu M; Künkele A; Hu J; Thole T; Schweizer L; Mechtersheimer G; Carter D; Cheung BB; Popanda O; von Deimling A; Koster J; Versteeg R; Schwab M; Marshall GM; Speleman F; Erb U; Zoeller M; Allgayer H; Simon T; Fischer M; Kulozik AE; Eggert A; Witt O; Schulte JH; Deubzer HE
    Oncotarget; 2016 Oct; 7(41):66344-66359. PubMed ID: 27572323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD9 Tetraspanin: A New Pathway for the Regulation of Inflammation?
    Brosseau C; Colas L; Magnan A; Brouard S
    Front Immunol; 2018; 9():2316. PubMed ID: 30356731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of tetraspanin CD9 with transmembrane TGF{alpha} confers alterations in cell-surface presentation of TGF{alpha} and cytoskeletal organization.
    Imhof I; Gasper WJ; Derynck R
    J Cell Sci; 2008 Jul; 121(Pt 13):2265-74. PubMed ID: 18544636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD9 expression as a favorable prognostic marker for patients with malignant mesothelioma.
    Amatya VJ; Takeshima Y; Aoe K; Fujimoto N; Okamoto T; Yamada T; Kishimoto T; Morimoto C; Inai K
    Oncol Rep; 2013 Jan; 29(1):21-8. PubMed ID: 23128478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Impact of the CD9 Tetraspanin on Lentivirus Infectivity and Exosome Secretion.
    Böker KO; Lemus-Diaz N; Rinaldi Ferreira R; Schiller L; Schneider S; Gruber J
    Mol Ther; 2018 Feb; 26(2):634-647. PubMed ID: 29221804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD9 induces cellular senescence and aggravates atherosclerotic plaque formation.
    Cho JH; Kim EC; Son Y; Lee DW; Park YS; Choi JH; Cho KH; Kwon KS; Kim JR
    Cell Death Differ; 2020 Sep; 27(9):2681-2696. PubMed ID: 32346137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cd9 Protects Photoreceptors from Injury and Potentiates Edn2 Expression.
    Iwagawa T; Aihara Y; Umutoni D; Baba Y; Murakami A; Miyado K; Watanabe S
    Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):7. PubMed ID: 32150249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ablation of the CD9 receptor in human lung cancer cells using CRISPR/Cas alters migration to chemoattractants including IL-16.
    Blake DJ; Martiszus JD; Lone TH; Fenster SD
    Cytokine; 2018 Nov; 111():567-570. PubMed ID: 29884309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tetraspanin CD9: A Key Regulator of Cell Adhesion in the Immune System.
    Reyes R; Cardeñes B; Machado-Pineda Y; Cabañas C
    Front Immunol; 2018; 9():863. PubMed ID: 29760699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.